| 000 | 01881 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250511201114.0 | ||
| 264 | 0 | _c19900927 | |
| 008 | 199009s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19900815)66:4<632::aid-cncr2820660405>3.0.co;2-b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLicht, J D | |
| 245 | 0 | 0 |
_aTreatment of low-grade and intermediate-grade lymphoma with intensive combination chemotherapy results in long-term, disease-free survival. _h[electronic resource] |
| 260 |
_bCancer _cAug 1990 |
||
| 300 |
_a632-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aBosserman, L D | |
| 700 | 1 | _aAndersen, J W | |
| 700 | 1 | _aYeap, B Y | |
| 700 | 1 | _aKlatt, M M | |
| 700 | 1 | _aMartel, J K | |
| 700 | 1 | _aAnderson, K C | |
| 700 | 1 | _aRosenthal, D S | |
| 700 | 1 | _aPinkus, G | |
| 700 | 1 | _aSkarin, A T | |
| 773 | 0 |
_tCancer _gvol. 66 _gno. 4 _gp. 632-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19900815)66:4<632::aid-cncr2820660405>3.0.co;2-b _zAvailable from publisher's website |
| 999 |
_c1703246 _d1703246 |
||